Fundraising Fox
Alaunos Therapeutics
NASDAQ: TCRT1 known investors
Find your way into Alaunos Therapeutics
Sign up to see every warm intro you have to Alaunos Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alaunos Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alaunos Therapeutics is developing an oral small-molecule therapeutic for obesity and other metabolic disorders that does not rely on hormonal manipulation. The company has identified a lead compound in preclinical evaluation and is conducting studies to inform IND-enabling work.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements$2M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountprivate placementJun 2025Source ↗
- $2Mregistered direct offeringJun 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Alaunos Therapeutics do?
- Alaunos Therapeutics is developing an oral small-molecule therapeutic for obesity and other metabolic disorders that does not rely on hormonal manipulation. The company has identified a lead compound in preclinical evaluation and is conducting studies to inform IND-enabling work.
- Who are Alaunos Therapeutics's investors?
- Alaunos Therapeutics's investors include Khosla Ventures.
- How much funding has Alaunos Therapeutics raised?
- Alaunos Therapeutics has disclosed $2M raised across 1 of its 2 known rounds.